Stonepine Capital Management LLC Raises Holdings in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)

Stonepine Capital Management LLC boosted its stake in shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) by 9.9% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 752,088 shares of the company’s stock after purchasing an additional 67,580 shares during […]

Related Keywords

Canada , ,Nasdaq ,Jpmorgan Chase Co ,Stonepine Capital Management ,Advisor Group Holdings Inc ,Atea Pharmaceuticals ,Alpine Global Management ,News Ratings For Atea Pharmaceuticals Daily ,Atea Pharmaceuticals Price Performance ,Royal Bank ,Atea Pharmaceuticals Inc ,Exchange Commission ,Quarter For Atea Pharmaceuticals ,Wealth Concepts ,Osaic Holdings Inc ,Free Report ,Capital Management ,Group Holdings ,Atea Pharmaceuticals Daily ,Nasdaq Avir ,Tavir ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,